98%
921
2 minutes
20
Background: Transverse open aortic arch replacement remains a complex operation. A simplified arch replacement into zone 2, with debranching the head vessels proximally, creates a suitable landing zone for future endovascular repair and is increasing in popularity as of late. Still, limited data exist to assess contemporary rates of morbidity and mortality. Therefore, we aim to evaluate current outcomes for patients who underwent open zone 2 aortic arch replacement.
Methods: All patients who underwent zone 2 arch replacement at a single academic institution from January 2019 to June 2023 were assessed. Indication for operation was either aneurysmal disease ( = 37), acute aortic syndrome ( = 38), or residual arch/descending thoracic aorta dissection ( = 67). Patient demographics and operative characteristics were evaluated, and the frequency of subsequent thoracic endovascular aortic repair (TEVAR) was noted. Mortality and major morbidity were then assessed.
Results: A total of 142 patients underwent open zone 2 arch replacement. Median cardiopulmonary bypass, cross-clamp, and deep hypothermic circulatory arrest times for the entire cohort were 195, 122, and 36.5 minutes, respectively. Concomitant frozen elephant trunk was performed in 45.1% of the cohort ( = 64). In-hospital mortality was 7.8% ( = 11) for the entire cohort. Spinal cord ischemia occurred in 3.5% ( = 5); these patients all received frozen elephant trunks and had neurologic recovery by discharge. Stroke occurred in 9.2% ( = 13) of the study cohort. A total of 38.7% ( = 55) went on to get subsequent TEVAR, with median time to TEVAR of 52 days (8, 98.5).
Conclusion: Zone 2 arch replacement allows staged repair of the thoracic aorta and readily accommodates future TEVAR therapy. This option for the treatment of the aortic arch can be performed safely in a wide variety of patient pathologies. Given the safety of this operation, cardiac surgeons should utilize this approach more frequently.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688148 | PMC |
http://dx.doi.org/10.1055/s-0044-1795130 | DOI Listing |
Thorac Cardiovasc Surg
September 2025
West Georgia Heart Center, Tbilisi State Medical University, Kutaisi, Georgia.
DeBakey type I aortic dissection requires circulatory arrest during arch reconstruction, putting the brain at risk. In resource-limited centers, deep hypothermia can exacerbate coagulopathy and lead to increased bleeding. This study compares outcomes between mild and moderate hypothermia under unilateral cerebral perfusion (UCP).
View Article and Find Full Text PDFArch Med Res
September 2025
Unidad de Investigación Médica en Trombosis, Hemostasia y Aterogénesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Electronic address:
Introduction: Treatment of patients with severe hemophilia A requires the replacement of deficient factor VIII. To reach the international standards of care, an optimal dose of factor VIII should be administered based on pharmacokinetic analysis. However, in Mexico factor VIII pharmacokinetics is not used.
View Article and Find Full Text PDFAlgorithms and tools are frequently utilized in emergency medicine workflows. Focusing on selective information, they are at risk of missing patients with atypical presentations of sometimes life-threatening conditions. This case report highlights a female patient in her late 70s who was transferred to the emergency department due to vomiting and diarrhea after eating raw fish for lunch.
View Article and Find Full Text PDFArch Cardiovasc Dis
August 2025
ACHD Unit, cardiologie, institut du thorax, CHU de Nantes, Nantes université, 44000 Nantes, France; Interventional Cardiology Department, institut du thorax, CHU de Nantes, Nantes université, 44000 Nantes, France; Institut du thorax, CNRS, Inserm, CHU de Nantes, Nantes université, 44000 Nantes, F
PLoS One
September 2025
Department of Surgery, Roi Et Hospital, Roi Et, Thailand.
Objectives: To systematically review propensity score-matched studies comparing hybrid arch repair (HAR) with total arch replacement (TAR) for aortic arch pathologies, summarizing early outcomes and intermediate-term results.
Methods: We searched PubMed, Embase, the Cochrane Library, and Google Scholar to April 2024. The primary outcome was in-hospital mortality, evaluated by a random-effects model to calculate the odds ratio (OR).